Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000726443 | SCV000528117 | likely benign | not provided | 2021-03-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000726443 | SCV000701411 | uncertain significance | not provided | 2017-01-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087715 | SCV001015913 | likely benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000726443 | SCV001145101 | benign | not provided | 2018-12-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000726443 | SCV004163470 | likely benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | PLEC: BP4, BP7 |
Prevention |
RCV004737482 | SCV005344699 | benign | PLEC-related disorder | 2024-07-16 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |